Tumour Marker Screening
Stay Proactive About Prostate and Cancer Health
As you age, maintaining awareness of your overall cancer risk becomes increasingly important. The Tumour Marker Screening (CEA & PSA) test is a simple at-home blood test that measures two key biomarkers linked to cancer risk and early detection.
-
Prostate-Specific Antigen (PSA): a protein produced by the prostate gland, used to assess prostate health and identify potential prostate-related conditions.
-
Carcinoembryonic Antigen (CEA): a general tumour marker that can help indicate changes related to cancers of the colon, rectum, lung, breast, pancreas, or thyroid.
Whether you’re proactively monitoring your health or addressing symptoms such as changes in urination, unexplained fatigue, pain, or weight loss, this dual test provides valuable data to share with your doctor and helps you stay ahead of potential concerns through early awareness.
What You'll Discover
This test measures the levels of Prostate-Specific Antigen (PSA) and Carcinoembryonic Antigen (CEA) in your bloodstream — two important tumour markers that can provide early insight into potential health concerns.
PSA is a protein made by the prostate gland; elevated levels may indicate prostate cancer, benign prostatic hyperplasia (BPH), or inflammation of the prostate. CEA is a general tumour marker that can become raised in certain cancers of the colon, rectum, pancreas, breast, lung, or thyroid, as well as in some non-cancerous conditions.
It’s important to note that raised levels of either marker don’t always mean cancer, and normal levels don’t rule out all issues. This test is designed as an early screening tool to help you better understand your risk and discuss next steps with your healthcare provider.
If you’re experiencing urinary symptoms, pelvic discomfort, unexplained fatigue, or simply want peace of mind about your overall health, this test helps bring clarity and supports early intervention when needed.
Why Take This Test?
Prostate and other tumour-related conditions often develop silently, showing few or no symptoms until they become more advanced. Regular screening helps detect changes early and provides valuable peace of mind.
This Tumour Marker Screening (PSA & CEA) test is especially beneficial for men over the age of 50, those with a family history of prostate or colorectal cancer, or anyone noticing changes in urinary, digestive, or sexual function.
It can also be used to track PSA and CEA levels over time, particularly if you’re already working with a healthcare provider or undergoing treatment, allowing you to monitor progress and support early intervention where necessary.
Start your journey to better health, today.